2Bailey RC,Moses S,Parker CB,et al. Male circumcision forHIV prevention in young men in Kisumu, Kenya: a randomisedcontrolled trial[J]. Lancet, 2007, 369(9562) : 643 - 656.
3Gray RH,Kigozi G, Serwadda D,et al. Male circumcision forHIV prevention in men in Rakai* Uganda: a randomised trial[J]. Lancet, 2007,369(9562) : 657 - 666.
4Ramjee G,Govinden R, Morar NS,et al. South Africa's experi-ence of the closure of the cellulose sulphate microbicide trial [J].PLoS Med, 2007,4(7): e235.
5Pitisuttithum P,Gilbert P, Gurwith M, et al. Randomized, doubleblind, placebo controlled efficacy trial of a bivalent recombinant glyco-protein 120 HIV-1 vaccine among injection drug users in Bangkok,Thailand [J]. J Infect Dis, 2006,194(12) : 1661 - 1671.
7Anderson PL, Kiser JJ, Gardner EM, et al. Pharmacologicalconsiderations for tenofovir and emtricitabine to prevent HIV in-fection[J]. J Antimicrob Chemother,2011,66(2) :240 -250.
9Centers for Disease Control and Prevention (CDC). Interim guid-ance: preexposure prophylaxis for the prevention of HIV infec-tion in men who have sex with men[J]. MMWR Morb MortalWkly Rep,2011,60(3) :65 -68.
